Janet K. Horton MD
Breast Cancer
Assistant Professor, Radiation Oncology, Duke University School of Medicine
Join to View Full Profile
S Hawthorne RdWinston Salem, NC 27157
Phone+1 336-716-2255
Dr. Horton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of North Carolina HospitalsResidency, Radiation Oncology, 2002 - 2006
Cone HealthInternship, Internal Medicine, 2001 - 2002
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2001
Certifications & Licensure
NC State Medical License 2002 - 2025
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Single Dose Partial Breast Radiotherapy Start of enrollment: 2010 Jul 28
- Veliparib With Radiation Therapy in Patients With Inflammatory or Loco-regionally Recurrent Breast Cancer Start of enrollment: 2012 Jan 01
- Self-Reported Exercise Behavior and Short-Term Patient Outcomes in Women Undergoing Radiation Treatment for Operable Breast Cancer Start of enrollment: 2014 Jan 01
Publications & Presentations
PubMed
- 18 citationsTrilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final Efficacy and Subgroup Analysis from a Randomized Phase II Study.Antoinette R Tan, Gail S Wright, Anu R Thummala, Michael A Danso, Lazar Popovic
Clinical Cancer Research. 2022-02-15 - 110 citationsManagement of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline.Muriel Brackstone, Fulvia Baldassarre, Francisco E. Perera, Tulin Cil, Mariana Chavez-Mac Gregor
Journal of Clinical Oncology. 2021-07-19 - 9 citationsExploratory composite endpoint demonstrates benefit of trilaciclib across multiple clinically meaningful components of myeloprotection in patients with small cell lung...Manuel Dómine Gómez, Tibor Csőszi, Jana Jaal, Iveta Kudaba, Krasimir Nikolov
International Journal of Cancer. 2021-07-10
Press Mentions
Study Finds Stereotactic Body Radiotherapy Is Safe for Treating Patients with Multiple MetastasesApril 21st, 2021- 2017 Red Journal Conflict of Interest/PhotographsAugust 18th, 2017
Du Kanske Också GillarNovember 18th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
